XML 14 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Net Sales $ 1,832.8 $ 1,762.2 $ 5,670.8 $ 4,064.2
Cost of products sold, excluding intangible asset amortization 479.3 552.1 1,760.0 1,131.3
Intangible asset amortization 164.3 122.6 424.7 176.0
Research and development 95.6 83.3 269.9 182.9
Selling, general and administrative 727.7 692.3 2,176.6 1,560.6
Certain claims (Note 15)       7.7
Special items (Note 2) 170.4 195.9 397.0 751.9
Operating expenses 1,637.3 1,646.2 5,028.2 3,810.4
Operating Profit 195.5 116.0 642.6 253.8
Other (expense) income, net (1.1) 4.3 (8.7) (44.6)
Interest income 0.6 2.3 2.7 7.4
Interest expense (91.5) (90.8) (267.8) (196.6)
Earnings before income taxes 103.5 31.8 368.8 20.0
(Benefit) provision for income taxes (54.4) 9.6 133.9 0.5
Net Earnings 157.9 22.2 234.9 19.5
Less: Net loss attributable to noncontrolling interest (0.9)   (1.4) (0.5)
Net Earnings of Zimmer Biomet Holdings, Inc. $ 158.8 $ 22.2 $ 236.3 $ 20.0
Earnings Per Common Share        
Basic $ 0.79 $ 0.11 $ 1.18 $ 0.11
Diluted $ 0.78 $ 0.11 $ 1.17 $ 0.11
Weighted Average Common Shares Outstanding        
Basic 200.1 203.5 199.9 182.1
Diluted 202.9 205.7 202.3 184.7
Cash Dividends Declared Per Common Share $ 0.24 $ 0.22 $ 0.72 $ 0.66